Atossa Therapeutics, Inc.
ATOS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001488039
No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Atossa Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 49 | 67 | +18 |
| Shares | 16.0M | 19.2M | +3.27M (+20.5%) |
| Value | $14.1M | $34.6M | +$20.5M (+145.6%) |
New holders (22)
Institutions that held Atossa Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 628,554 | $1.13M | 0.00% |
| HRT Financial LP | 291,421 | $524.0K | 0.00% |
| Citigroup Inc | 182,872 | $329.2K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 140,858 | $253.5K | 0.07% |
| Y-Intercept (Hong Kong) Ltd | 114,341 | $205.8K | 0.02% |
| Virtu Financial LLC | 83,941 | $151.0K | 0.01% |
| Simplex Trading, LLC | 55,589 | $100.0K | 0.00% |
| Wolverine Trading, LLC | 48,931 | $88.1K | 0.00% |
| Cetera Investment Advisers | 46,730 | $84.1K | 0.00% |
| Balyasny Asset Management LLC | 42,981 | $77.4K | 0.00% |
| Jane Street Group, LLC | 39,053 | $70.3K | 0.00% |
| Jefferies Financial Group Inc. | 38,200 | $68.8K | 0.00% |
| CTC Alternative Strategies, Ltd. | 36,300 | $65.3K | 0.04% |
| Two Sigma Securities, LLC | 34,579 | $62.2K | 0.00% |
| ExodusPoint Capital Management, LP | 25,960 | $47.0K | 0.00% |
| PFG Investments, LLC | 23,650 | $42.6K | 0.00% |
| Brevan Howard Capital Management LP | 13,666 | $24.6K | 0.00% |
| DRW Securities, LLC | 12,800 | $23.0K | 0.00% |
| Silicon Valley Capital Partners | 3,875 | $6.97K | 0.00% |
| Old Point Trust & Financial Services N A | 250 | $450 | 0.00% |
| Macquarie Group Ltd | 1,735 | $3 | 0.00% |
| NBC Securities, Inc. | 150 | – | – |
Sold out (4)
Institutions that held Atossa Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Gsa Capital Partners LLP | 449,082 | $395.0K |
| Bank of Montreal | 352,700 | $359.8K |
| XTX Topco Ltd | 85,369 | $75.1K |
| Castleview Partners, LLC | 500 | $440 |